XML 87 R70.htm IDEA: XBRL DOCUMENT
v3.24.0.1

EMPLOYEE BENEFIT PLANS - Expected Benefit Payments, Net (Details) $ in Thousands | Dec. 31, 2023 USD ($)
--- | ---
Other Benefits |
Expected Benefit Payments Before Medicare Part D Subsidy |
2024 | $ 4,712
2025 | 5,011
2026 | 5,353
2027 | 5,782
2028 | 6,234
2029-2033 | 38,176
Total payments | 65,268
Effect of Medicare Part D Subsidy on Expected Benefit Payments |
2024 | (248)
2025 | (275)
2026 | (302)
2027 | (329)
2028 | (358)
2029-2033 | (2,209)
Total payments | (3,721)
Expected Benefit Payments Net of Medicare Part D Subsidy |
2024 | 4,712
2025 | 5,011
2026 | 5,353
2027 | 5,782
2028 | 6,234
2029-2033 | 38,176
Postretirement Health Coverage [Member] |
Expected Benefit Payments Before Medicare Part D Subsidy |
2024 | 4,464
2025 | 4,736
2026 | 5,051
2027 | 5,453
2028 | 5,876
2029-2033 | 35,967
Expected Benefit Payments Net of Medicare Part D Subsidy |
2024 | 4,464
2025 | 4,736
2026 | 5,051
2027 | 5,453
2028 | 5,876
2029-2033 | 35,967
Total payments | $ 61,547

X
- Definition Defined Benefit Plan, Expected Future Benefit Payment, Net Prescription Drug Subsidy Receipts [Abstract] + References No definition available. + Details
Name: | cwt_DefinedBenefitPlanExpectedFutureBenefitPaymentNetPrescriptionDrugSubsidyReceiptsAbstract
Namespace Prefix: | cwt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Defined Benefit Plan, Expected Future Benefit Payments + References No definition available. + Details
Name: | cwt_DefinedBenefitPlanExpectedFutureBenefitPayments
Namespace Prefix: | cwt_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Defined Benefit Plan, Expected Future Benefit Payments, Gross + References No definition available. + Details
Name: | cwt_DefinedBenefitPlanExpectedFutureBenefitPaymentsGross
Namespace Prefix: | cwt_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipts + References No definition available. + Details
Name: | cwt_DefinedBenefitPlanExpectedFuturePrescriptionDrugSubsidyReceipts
Namespace Prefix: | cwt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfExpectedGrossPrescriptionDrugSubsidyReceiptsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of prescription drug subsidy receipt expected after fifth fiscal year following current fiscal year. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 60 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_PrescriptionDrugSubsidyReceiptsAfterYearFive
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of prescription drug subsidy receipt expected in next fiscal year following current fiscal year. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 60 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_PrescriptionDrugSubsidyReceiptsNextTwelveMonths
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of prescription drug subsidy receipt expected in fifth fiscal year following current fiscal year. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 60 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_PrescriptionDrugSubsidyReceiptsYearFive1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of prescription drug subsidy receipt expected in fourth fiscal year following current fiscal year. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 60 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_PrescriptionDrugSubsidyReceiptsYearFour1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of prescription drug subsidy receipt expected in third fiscal year following current fiscal year. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 60 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_PrescriptionDrugSubsidyReceiptsYearThree1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of prescription drug subsidy receipt expected in second fiscal year following current fiscal year. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 60 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_PrescriptionDrugSubsidyReceiptsYearTwo1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RetirementPlanTypeAxis=us-gaap_DefinedBenefitPostretirementHealthCoverageMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |